Cagrilintide (10mg) – Aussie Peptides

🌟 Next-generation long-acting amylin analogue for advanced metabolic research.

⚠️ For Research Purposes Only

$150.00 AUD

Ask a Question

Product Overview

Cagrilintide is an innovative, long-acting amylin receptor agonist designed for extended pharmacokinetic properties. This peptide analogue has attracted significant research interest due to its potential role in energy homeostasis, appetite regulation, and metabolic pathway modulation.

Each vial contains 10mg of highly purified lyophilized Cagrilintide, produced under rigorous quality control standards for research applications.

Specifications

Purity ≥98% (HPLC verified)

Format Lyophilized powder

Quantity 10mg per vial

Type Amylin receptor agonist

Mechanism Activates amylin receptors

Storage -20°C, protect from light

Research Background

Cagrilintide represents an important advancement in the field of amylin analogues, with emerging research highlighting its potential in metabolic pathway investigations. The following information is derived from published scientific literature and is provided solely for research context:

Synergistic Effects with GLP-1 Agonists

Research models have demonstrated significant synergistic effects when Cagrilintide is studied alongside GLP-1 receptor agonists. This dual-pathway approach has yielded enhanced metabolic outcomes beyond what either compound achieved individually in preclinical investigations.

Source: Cell Metabolism, 2022

Appetite Regulation Mechanisms

Studies have explored Cagrilintide's effects on central appetite regulation pathways, observing prolonged activation of amylin receptors in hypothalamic regions associated with satiety signaling and food reward processing. These mechanisms provide valuable research models for energy intake regulation.

Source: Journal of Clinical Investigation, 2021

Metabolic Parameter Improvements

Research has documented improvements in multiple metabolic parameters in experimental models, including enhanced insulin sensitivity, reduced hepatic glucose output, and improved lipid profiles. These multi-system effects suggest broad research applications in metabolic pathway investigation.

Source: Diabetes Care, 2023

Suggested Research Application

Cagrilintide may be reconstituted with sterile water or appropriate buffer solutions under aseptic laboratory conditions. The compound's extended half-life allows for less frequent administration in experimental protocols, potentially enhancing research efficiency.

For optimal stability, store lyophilized peptide at -20°C and protect from light and moisture. Once reconstituted, store at 2-8°C and use within 7 days for maximum potency. Avoid repeated freeze-thaw cycles which may compromise peptide integrity.

Important Notice

This product is NOT a therapeutic good as defined by the Therapeutic Goods Act 1989. It is not intended for human use or ingestion. For laboratory, educational, and scientific research purposes only. Use in animals or humans is strictly prohibited unless explicitly approved by a relevant authority.